Purpose: To report a case of orbital cellular epithelioid hemangioma (EH) in which FOSB and CAMTA1 immunostains were used to detect a cytogenetic rearrangement as an adjunctive tool in diagnosis. Methods: Case report. Results: A patient with a history of prior ligation of a presumed orbital varix presented with recurrent proptosis. Imaging revealed a highly vascular right orbital mass. Microscopic examination revealed a circumscribed neoplasm composed of plump epithelioid endothelial cells with copious mildly eosinophilic cytoplasm and relatively uniform vesicular nuclei. To aid in diagnosis, immunostains for FOSB and CAMTA1 were performed to detect corresponding cytogenetic rearrangements. The presence of multifocal nuclear positivity for FOSB, indicating FOSB genetic rearrangement, and negativity for CAMTA1 were considered reassuring features against a diagnosis of a malignant epithelioid hemangioendothelioma (EHE), supporting a diagnosis of benign cellular EH. Conclusions: This case report demonstrates that the use of immunohistochemical stains to detect cytogenetic rearrangements may aid in the distinction between benign EH and malignant EHE. It also reminds providers of the clinical and histopathologic features of this lesion, which occurs rarely in the orbit, and helps clarify the evolving nomenclature surrounding epithelioid hemangioma.

1.
Fletcher
CD
,
Bridge
JA
,
Hogendoorn
PC
,
Mertens
F
.
WHO Classification of Tumours of Soft Tissue and Bone
.
Volume 5
. 4th ed.
Lyon, France
:
IARC Press
;
2013
.
2.
Huang
SC
,
Zhang
L
,
Sung
YS
,
Chen
CL
,
Krausz
T
,
Dickson
BC
, et al
Frequent FOS gene rearrangements in epithelioid hemangioma: a molecular study of 58 cases with morphologic reappraisal
.
Am J Surg Pathol
.
2015
Oct
;
39
(
10
):
1313
21
.
[PubMed]
0147-5185
3.
Wells
GC
,
Whimster
IW
.
Subcutaneous angiolymphoid hyperplasia with eosinophilia
.
Br J Dermatol
.
1969
Jan
;
81
(
1
):
1
14
.
[PubMed]
0007-0963
4.
Rosai
J
,
Gold
J
,
Landy
R
.
The histiocytoid hemangiomas. A unifying concept embracing several previously described entities of skin, soft tissue, large vessels, bone, and heart
.
Hum Pathol
.
1979
Nov
;
10
(
6
):
707
30
.
[PubMed]
0046-8177
5.
Weiss
SW
,
Enzinger
FM
.
Epithelioid hemangioendothelioma: a vascular tumor often mistaken for a carcinoma
.
Cancer
.
1982
Sep
;
50
(
5
):
970
81
.
[PubMed]
0008-543X
6.
Rosai
J
,
Akerman
LR
.
Intravenous atypical vascular proliferation. A cutaneous lesion simulating a malignant blood vessel tumor
.
Arch Dermatol
.
1974
May
;
109
(
5
):
714
7
.
[PubMed]
0003-987X
7.
Jones
EW
,
Bleehen
SS
.
Inflammatory angiomatous nodules with abnormal blood vessels occurring about the ears and scalp (pseudo or atypical pyogenic granuloma)
.
Br J Dermatol
.
1969
Nov
;
81
(
11
):
804
16
.
[PubMed]
0007-0963
8.
Googe
PB
,
Harris
NL
,
Mihm
MC
 Jr
.
Kimura’s disease and angiolymphoid hyperplasia with eosinophilia: two distinct histopathological entities
.
J Cutan Pathol
.
1987
Oct
;
14
(
5
):
263
71
.
[PubMed]
0303-6987
9.
Buggage
RR
,
Spraul
CW
,
Wojno
TH
,
Grossniklaus
HE
.
Kimura disease of the orbit and ocular adnexa
.
Surv Ophthalmol
.
1999
Jul-Aug
;
44
(
1
):
79
91
.
[PubMed]
0039-6257
10.
Azari
AA
,
Kanavi
MR
,
Lucarelli
M
,
Lee
V
,
Lundin
AM
,
Potter
HD
, et al
Angiolymphoid hyperplasia with eosinophilia of the orbit and ocular adnexa: report of 5 cases
.
JAMA Ophthalmol
.
2014
May
;
132
(
5
):
633
6
.
[PubMed]
2168-6165
11.
Mukherjee
B
,
Kadaskar
J
,
Priyadarshini
O
,
Krishnakumar
S
,
Biswas
J
.
Angiolymphoid hyperplasia with eosinophilia of the orbit and adnexa
.
Ocul Oncol Pathol
.
2015
Sep
;
2
(
1
):
40
7
.
[PubMed]
2296-4681
12.
Hidayat
AA
,
Cameron
JD
,
Font
RL
,
Zimmerman
LE
.
Angiolymphoid hyperplasia with eosinophilia (Kimura’s disease) of the orbit and ocular adnexa
.
Am J Ophthalmol
.
1983
Aug
;
96
(
2
):
176
89
.
[PubMed]
0002-9394
13.
Sánchez-Acosta
A
,
Moreno-Arredondo
D
,
Rubio-Solornio
RI
,
Rodríguez-Martínez
HA
,
Rodríguez-Reyes
AA
.
Angiolymphoid hyperplasia with eosinophilia of the lacrimal gland: a case report
.
Orbit
.
2008
;
27
(
3
):
195
8
.
[PubMed]
0167-6830
14.
Cook
HT
,
Stafford
ND
.
Angiolymphoid hyperplasia with eosinophilia involving the lacrimal gland: case report
.
Br J Ophthalmol
.
1988
Sep
;
72
(
9
):
710
2
.
[PubMed]
0007-1161
15.
Shields
CL
,
Shields
JL
,
Glass
RN
.
Bilateral orbit involvement with angiolymphoid hyperplasia with eosinophilia
.
Orbit
.
1995
;
9
:
89
95
. 0167-6830
16.
Bostad
L
,
Pettersen
W
.
Angiolymphoid hyperplasia with eosinophilia involving the orbita. A case report
.
Acta Ophthalmol (Copenh)
.
1982
Jun
;
60
(
3
):
419
26
.
[PubMed]
0001-639X
17.
Eisenberg
E
,
Lowlicht
R
.
Angiolymphoid hyperplasia with eosinophils: a clinical-pathological conference
.
J Oral Pathol
.
1985
Mar
;
14
(
3
):
216
23
.
[PubMed]
0300-9777
18.
Kennedy
SM
,
Pitts
JF
,
Lee
WR
,
Gibbons
DC
.
Bilateral Kimura’s disease of the eyelids
.
Br J Ophthalmol
.
1992
Dec
;
76
(
12
):
755
7
.
[PubMed]
0007-1161
19.
Alder
B
,
Proia
A
,
Liss
J
.
Distinct, bilateral epithelioid hemangioma of the orbit
.
Orbit
.
2013
Feb
;
32
(
1
):
51
3
.
[PubMed]
0167-6830
20.
Urabe
A
,
Tsuneyoshi
M
,
Enjoji
M
.
Epithelioid hemangioma versus Kimura’s disease. A comparative clinicopathologic study
.
Am J Surg Pathol
.
1987
Oct
;
11
(
10
):
758
66
.
[PubMed]
0147-5185
21.
Antonescu
CR
,
Chen
HW
,
Zhang
L
,
Sung
YS
,
Panicek
D
,
Agaram
NP
, et al
ZFP36-FOSB fusion defines a subset of epithelioid hemangioma with atypical features
.
Genes Chromosomes Cancer
.
2014
Nov
;
53
(
11
):
951
9
.
[PubMed]
1045-2257
22.
Tanas
MR
,
Sboner
A
,
Oliveira
AM
,
Erickson-Johnson
MR
,
Hespelt
J
,
Hanwright
PJ
, et al
Identification of a disease-defining gene fusion in epithelioid hemangioendothelioma
.
Sci Transl Med
.
2011
Aug
;
3
(
98
):
98ra82
.
[PubMed]
1946-6234
23.
Antonescu
CR
,
Le Loarer
F
,
Mosquera
JM
,
Sboner
A
,
Zhang
L
,
Chen
CL
, et al
Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma
.
Genes Chromosomes Cancer
.
2013
Aug
;
52
(
8
):
775
84
.
[PubMed]
1045-2257
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.